Effect of Intermittent Endogenous Hyperglucagonemia on Glucose Homeostasis in Normal and Diabetic Man
Open accessAbstract
UNLABELLED: Infusion of glucagon causes only a transient increase in glucose production in normal and diabetic man. To assess the effect of intermittent endogenous hyperglucagonemia that might more closely reflect physiologic conditions, arginine (10 g over 30 min) was infused four times to 8 normal subjects and 13 insulin-dependent diabetic subjects (4 of whom were infused concomitantly with somatostatin to examine effects of arginine during prevention of hyperglucagonemia). Each arginine infusion was separated by 60 min. Diabetic subjects were infused throughout the experiments with insulin at rates (0.07-0.48 mU/kg per min) that had normalized base-line plasma glucose and rates of glucose appearance (Ra) and disappearance (Rd). Basal plasma glucagon and arginine-induced hyperglucagonemia were similar in both groups; basal serum insulin in the diabetics (16+/-1 muU/ml, P < 0.05) exceeded those of the normal subjects (10+/-1 muU/ml, P < 0.05) but did not increase with arginine. Serum insulin in normal subjects increased 15-20 muU/ml with each arginine infusion. In both groups each arginine infusion increased plasma glucose and Ra. Increments of Ra in the diabetics exceeded those of normal subjects, (P < 0.02); Rd was similar in both groups. In normal subjects, plasma glucose returned to basal levels after each arginine infusion, whereas in the diabetics hyperglycemia persisted reaching 151+/-15 mg/dl after the last arginine infusion. When glucagon responses were prevented by somatostatin, arginine infusions did not alter plasma glucose or Ra. CONCLUSIONS: Infusion of arginine acutely increases plasma glucose and glucose production in man solely by stimulating glucagon secretion; physiologic increments in plasma glucagon (100-150 pg/ml) can result in sustained hyperglycemia when pancreatic beta cell function is limited.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Glucagon and epinephrine are rapidly acting counterregulatory hormones.
“Also, glucagon and epinephrine are rapidly acting counterregulatory hormones (4, 5).”
From Mechanisms of postprandial glucose counterregulation in man. Physiologic roles of glucagon and epinephrine vis-a-vis insulin in the prevention of hypoglycemia late after glucose ingestion (1983) · cites this paper as [5]
The Results (page unavailable) report that plasma glucose and glucose appearance promptly increased when glucagon infusion was increased, supporting a rapid glucagon effect. The paper does not establish the corresponding claim about epinephrine; a search for epinephrine found no passage addressing its action. (LLM, conf=0.88)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Hyperglucagonemia and Blood Glucose Regulation in Normal, Obese and Diabetic Subjects
Sherwin, R. S., Fisher, M., Hendler, R., & Felig, P. (1976) · New England Journal of Medicine · doi:10.1056/nejm197602262940901 · Cited by 252 · see citing works
Flagged first, then by citations
Research works printed but not linked: 3
- Park, C., and J. Exton. 1972. Glucagon and the metabolism ofglucose. In Glucagon, Molecular Physiology and Thera- peutic Implications. P. Lefebvre and R. Unger, editors. Pergammon Press, Inc., New York. 17-108.
- Faloona, G., and R. Unger. 1974. Glucagon. In Methods of Hormone Radioimmunoassay. B. Jaffee and H. Behr- man, editors. Academic Press, Inc., New York. 317-330.
- Radzuik, J., K. Norwich, and M. Vranic. 1974. Measure- ment and validation of nonsteady state turnover rates with applications to the insulin and glucose system. Fed. Proc. 33: 1855-1864.
Cited by
Sorted by citations
Influence of body fat distribution on free fatty acid metabolism in obesity.
Jensen, M. D., Haymond, M. W., Rizza, R. A., Cryer, P. E., & Miles, J. M. (1989) · Journal of Clinical Investigation · doi:10.1172/jci113997 · Cited by 683 · see citing works
Self-citationAdrenergic Mechanisms for the Effects of Epinephrine on Glucose Production and Clearance in Man
Rizza, R. A., Cryer, P. E., Haymond, M. W., & Gerich, J. E. (1980) · Journal of Clinical Investigation · doi:10.1172/jci109714 · Cited by 340 · see citing works
Self-citationDegn, K., Brock, B., Juhl, C. B., Djurhuus, C., Grubert, J., Kim, D. S., Han, J., Taylor, K., Fineman, M. S., & Schmitz, O. (2004) · Diabetes · doi:10.2337/diabetes.53.9.2397 · Cited by 253 · see citing works
“There may be several reasons: 1) the sensitivity of this experimental design was not sufficient to detect small differences in the recovery time, 2) the marked hyperinsulinemia was at a level that may have masked the opposing effects of differing levels of glucagon and potentially different amounts of releasable glyco…”
Failure of glucagon suppression contributes to postprandial hyperglycaemia in IDDM
Dinneen, S., Alzaid, A., Turk, D., & Rizza, R. (1995) · Diabetologia · doi:10.1007/bf00400639 · Cited by 190 · see citing works
Self-citationMechanism of metformin action in non-insulin-dependent diabetes
Jackson, R. A., Hawa, M. I., Jaspan, J. B., Sim, B. M., DiSilvio, L., Featherbe, D., & Kurtz, A. B. (1987) · Diabetes · doi:10.2337/diab.36.5.632 · Cited by 202 · see citing works
“Glucose space was assumed to be 20% of body weight (16,17), and the pool fraction was taken to be 0.”
Glucose Disposal is Not Proportional to Plasma Glucose Level in Man
Best, J., Taborsky, G., Halter, J., & Porte, D. (1981) · Diabetes · doi:10.2337/diab.30.10.847 · Cited by 188 · see citing works
Consoli, A., Kennedy, F., Miles, J., & Gerich, J. (1987) · Journal of Clinical Investigation · doi:10.1172/jci113206 · Cited by 170 · see citing works
Self-citationUnger, R. H., & Orci, L. (1981) · New England Journal of Medicine · doi:10.1056/nejm198106253042604 · Cited by 170 · see citing works
Gerich, J., Cryer, P., & Rizza, R. (1980) · Metabolism · doi:10.1016/0026-0495(80)90026-8 · Cited by 147 · see citing works
Self-citationInsulin as a physiological modulator of glucagon secretion
Bansal, P., & Wang, Q. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90295.2008 · Cited by 148 · see citing works
“Interestingly, clinical studies have demonstrated that challenge with glucagon results only in a transient and small rise in the glucose and insulin levels of healthy individuals (117).”
BackgroundMiles, J. M., Rizza, R. A., Haymond, M. W., & Gerich, J. E. (1980) · Diabetes · doi:10.2337/diab.29.11.926 · Cited by 142 · see citing works
Self-citationPehling, G., Tessari, P., Gerich, J., Haymond, M., Service, F., & Rizza, R. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111519 · Cited by 132 · see citing works
“Insulin therapy has been shown to enhance hyperglycemic-induced glycogen synthesis and the inhibition of glycogenolysis in vitro (11) to restore fasting rates of glucose production in diabetic subjects to the nondiabetic range (23, 24), and to restore the suppression of hepatic glucose release by intravenous glucose a…”
BackgroundSelf-citationJackson, R. A., Roshania, R. D., Hawa, M., Sim, B. M., & Disilvio, L. (1986) · Journal of Clinical Endocrinology and Metabolism · doi:10.1210/jcem-63-3-541 · Cited by 128 · see citing works
Hyperglucagonemia and insulin-mediated glucose metabolism.
Prato, S. D., Castellino, P., Simonson, D. C., & DeFronzo, R. A. (1987) · Journal of Clinical Investigation · doi:10.1172/jci112846 · Cited by 91 · see citing works
Raskin, P., Pietri, A., & Unger, R. H. (1979) · Diabetes · doi:10.2337/diab.28.11.1033 · Cited by 85 · see citing works
Nissenson, R., Abbott, S., Teitelbaum, A., Clark, O., & Arnaud, C. (1981) · Journal of Clinical Endocrinology and Metabolism · doi:10.1210/jcem-52-5-840 · Cited by 93
Tse, T. F., Clutter, W. E., Shah, S. D., & Cryer, P. E. (1983) · Journal of Clinical Investigation · doi:10.1172/jci110967 · Cited by 75 · see citing works
Effects of aging on glucose-mediated glucose disposal and glucose transport.
Fink, R., Wallace, P., & Olefsky, J. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112533 · Cited by 75 · see citing works
Differential effects of fasting and dehydration in the pathogenesis of diabetic ketoacidosis.
Burge, M., García, N., Qualls, C., & Schade, D. (2001) · Metabolism: Clinical and Experimental · doi:10.1053/meta.2001.20194 · Cited by 72 · see citing works
Effect of alpha-adrenergic stimulation and its blockade on glucose turnover in man.
Rizza, R., Haymond, M., Miles, J., Verdonk, C., Cryer, P., & Gerich, J. (1980) · American Journal of Physiology · doi:10.1152/ajpendo.1980.238.5.e467 · Cited by 60 · see citing works
Self-citationPreservation of insulin effects on glucose production and proteolysis during fasting.
Jensen, M. D., Miles, J. M., Gerich, J., Cryer, P., & Haymond, M. (1988) · American Journal of Physiology · doi:10.1152/ajpendo.1988.254.6.e700 · Cited by 55 · see citing works
Self-citationThe entero-insular axis: implications for human metabolism
Ranganath, L. R. (2007) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2008.008 · Cited by 58 · see citing works
Jackson, R. A., Hamling, J., Blix, P., Sim, B. M., Hawa, M., Jaspan, J., Belin, J., & Nabarro, J. (1986) · Journal of Clinical Endocrinology and Metabolism · doi:10.1210/jcem-63-3-594 · Cited by 49 · see citing works
Effects of Nonglucose Nutrients on Insulin Secretion and Action in People With Pre-Diabetes
Bock, G., Man, C. D., Campioni, M., Chittilapilly, E. G., Basu, R., TOFFOLO, G. M., Cobelli, C., & Rizza, R. A. (2007) · Diabetes · doi:10.2337/db06-1272 · Cited by 48 · see citing works
Self-citationNickel-induced hyperglycaemia: the role of insulin and glucagon.
Cartañà, J., & Arola, L. (1992) · Toxicology · doi:10.1016/0300-483x(92)90065-m · Cited by 45 · see citing works
Insulin-counteracting hormones: Their impact on glucose metabolism
Bratusch-Marrain, P. R. (1983) · Diabetologia · doi:10.1007/bf00297384 · Cited by 74 · see citing works
Minimizing Morbidity of Hypoglycemia in Diabetes
Chung, S. T., & Haymond, M. W. (2014) · Journal of Diabetes Science and Technology · doi:10.1177/1932296814547518 · Cited by 28 · see citing works
The Amino Acid-Induced Secretion of Glucagon
Assan, R., Marre, M., & Gormley, M. (1983) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-69019-8_2 · Cited by 24 · see citing works
Intra-islet glucagon secretion and action in the regulation of glucose homeostasis
Wang, Q., Liang, X., & Wang, S. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2012.00485 · Cited by 27 · see citing works
“…in sustained hyperglycemia as a consequence of stimulated gluconeogenesis and glycogenolysis in the liver (Gastaldelli et al., 2000; Shah et al., 2000), which, however, occurred only in human diabetic subjects with impaired β-cell function, but not in non-diabetic subjects (Rizza et al., 1979).”
Glucagon increases glutamine uptake without affecting glutamine release in humans.
Battezzati, A., Simonson, D., Luzi, L., & Matthews, D. (1998) · Metabolism: Clinical and Experimental · doi:10.1016/s0026-0495(98)90036-1 · Cited by 25 · see citing works
Effect of hyperglycemia per se on glucose disposal and clearance in noninsulin-dependent diabetics.
Best, J. D., Beard, J. C., Taborsky, G., Halter, J., & Porte, D. (1983) · Journal of Clinical Endocrinology and Metabolism · doi:10.1210/jcem-56-4-819 · Cited by 25
Heiling, V., Campbell, P. J., Gottesman, I., Tsalikian, E., Beaufrère, B., Gerich, J., & Haymond, M. W. (1993) · Journal of Clinical Endocrinology and Metabolism · doi:10.1210/jcem.76.1.8093620 · Cited by 25 · see citing works
Self-citationGerich, J. E. (1989) · Aufklärung und Einwilligung im Arztrecht, ESA · doi:10.1007/978-3-642-74255-2_10 · Cited by 20 · see citing works
Self-citationSolis-Herrera, C., Daniele, G., Alatrach, M., Agyin, C., Triplitt, C., Adams, J. M., Patel, R., Gastaldelli, A., Honka, H., Chen, X., et al. (2020) · Diabetes Care · doi:10.2337/dc19-2177 · Cited by 19 · see citing works
Jackson, R. A., Hamling, J., Blix, P., & Nabarro, J. (1984) · Journal of Clinical Endocrinology and Metabolism · doi:10.1210/jcem-59-5-857 · Cited by 18
Gruppuso, P. A., Susa, J. B., Doménech, M., Cha, C., & Schwartz, R. (1983) · Metabolism · doi:10.1016/0026-0495(83)90206-8 · Cited by 14 · see citing works
Kramer, C., Zinman, B., Choi, H., & Retnakaran, R. (2015) · Journal of Clinical Endocrinology and Metabolism · doi:10.1210/jc.2015-1947 · Cited by 16 · see citing works
“Hyperglucagonemia promotes increased hepatic gluconeogenesis and glycogenolysis, thereby contributing to hyperglycemia (3).”
BackgroundUnger, R. H., & Orci, L. (1983) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-69019-8_22 · Cited by 10 · see citing works
Komjati, M., Breitenecker, F., Bratusch-Marrain, P., Gampe, J., Vierhapper, H., Troch, I., & Waldhäusl, W. (1985) · Endocrinology · doi:10.1210/endo-116-3-978 · Cited by 15
Glucoregulatory disorders in school refusal students
Iwatani, N., Miike, T., Kai, Y., Kodama, M., Mabe, H., Tomoda, A., Fukuda, K., & Jodoi, T. (1997) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1997.2191095.x · Cited by 14 · see citing works
Lickley, H. L. A., Kemmer, F. W., Wasserman, D. H., & Vranić, M. (1983) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-69019-8_16 · Cited by 12 · see citing works
LINS, P.-E. S., Adamson, U., Clausen, N., Hamberger, B., & Efendić, S. (1986) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1986.tb02728.x · Cited by 8 · see citing works
Role of counterregulatory hormones in the regulation of hepatic glucose metabolism.
Saccá, L. (1987) · Diabetes Metabolism Reviews · doi:10.1002/dmr.5610030110 · Cited by 10 · see citing works
Rizza, R., Haymond, M., & Gerich, J. (1982) · Metabolism: Clinical and Experimental · doi:10.1016/0026-0495(82)90053-1 · Cited by 9 · see citing works
Self-citationMaharaj, A., Zhu, L., Huang, F., Qiu, H., Li, H., Zhang, C.-Y., Jin, T., & Wang, Q. (2012) · Diabetologia · doi:10.1007/s00125-012-2464-x · Cited by 8 · see citing works
“Interestingly, acute infusion of glucagon resulted in sustained hyperglycaemia only in human diabetic participants with impaired beta cell function, but not in non-diabetic participants [8].”
BackgroundBasal glucose homeostasis with and without fixed concentrations of glucagon and insulin.
Jackson, R. A., Hamling, J., Sim, B. M., Blix, P., Jaspan, J., Markanday, S., & Nabarro, J. (1987) · Metabolism: Clinical and Experimental · doi:10.1016/0026-0495(87)90006-0 · Cited by 8 · see citing works
Meier, J. J., Ueberberg, S., Korbas, S., & Schneider, S. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00315.2010 · Cited by 35 · see citing works
Metabolic Disturbances in Diabetes
Vella, A. V., & Rizza, R. A. (2010) · Wiley eBooks · doi:10.1002/9781444324808.ch13 · Cited by 5 · see citing works
Self-citationKuhre, R. E., Deacon, C. F., Albrechtsen, N. J. W., & Holst, J. J. (2021) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14422 · Cited by 6 · see citing works
Nakashima, K., Okamura, N., Sanefuji, H., & Kaneto, H. (2020) · Scientific Reports · doi:10.1038/s41598-020-58574-7 · Cited by 6 · see citing works
Assan, R., Efendić, S., Luft, R., & Cerasi, E. (1981) · Diabetologia · doi:10.1007/bf00257785 · Cited by 20 · see citing works
“Once diabetes is established glucagon oversecretion may play an important role in aggravating the characteristic metabolic disturbances [40-48] but our results support the idea that A cell dysfunction is not a primary cause of the disease.”
ResultThe genetics and pathophysiology of type II and gestational diabetes.
Tr, C., & Al, E. (1995) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408369509082593 · Cited by 6 · see citing works
Vaughan, N. J. A., Rao, R. H., Kurtz, A. B., Buckell, H. M., & Spathis, G. S. (1986) · Metabolism · doi:10.1016/0026-0495(86)90114-9 · Cited by 4 · see citing works
Mackes, K. G., Rizza, R. A., & Gerich, J. E. (1981) · Metabolism · doi:10.1016/0026-0495(81)90045-7 · Cited by 4 · see citing works
Self-citationGlucagon as a Counterregulatory Hormone
Gerich, J. E. (1983) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-69019-8_15 · Cited by 4 · see citing works
Self-citationPERNET, A., JOHNSTON, D. G., HAMMOND, V., ØRSKOV, H., & ALBERTI, K. G. M. M. (1986) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1986.tb01347.x · Cited by 4 · see citing works
Pre-Exposure to Glucagon Impairs Glucose Recovery after Insulin-Induced Hypoglycemia in Man
Clausen, N., Adamson, U., & Lins, P. (1987) · Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme · doi:10.1055/s-2007-1011828 · Cited by 4 · see citing works
The Pharmacology and Potential Clinical Applications of Somatostatin and its Analogues
Gerich, J. E. (1980) · Springer eBooks · doi:10.1007/978-94-011-7712-2_2 · Cited by 4 · see citing works
Self-citationEffect of danazol‐induced chronic hyperglucagonaemia on glucose tolerance and turnover
Kotzmann, H., Linkesch, M., Ludvik, B. H., Clodi, M., Luger, A., Schernthaner, G., Prager, R., & Klauser, R. (1995) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1995.tb01971.x · Cited by 4 · see citing works
[LeuB24]insulin is an insulin agonist at the liver in vivo.
Figlewicz, D., Best, J., Tager, H., & Taborsky, G. (1983) · American Journal of Physiology · doi:10.1152/ajpendo.1983.245.5.e483 · Cited by 3
Extended physiological models for the simulation of the glucose metabolism
Höfig, B., Kistner, A., Seibold, A., & Böhm, B. O. (1996) · Mathematical Modelling of Systems · doi:10.1080/13873959608837028 · Cited by 3 · see citing works
Type I Diabetes Mellitus (Insulin‐Dependent Diabetes Mellitus)
Rizza, R. A., Jensen, M. D., & Nair, K. S. (2001) · Comprehensive physiology · doi:10.1002/j.2040-4603.2001.tb01482.x
“Glucagon excess can exacerbate hyperglycemia both by increasing hepatic glucose release and by decreasing he-patic glucose uptake (40, 207, 226).”
Self-citationGlucagon and Glucagon‐like Peptide Production and Degradation
Kieffer, T. J., Hussain, M. A., & Habener, J. F. (2001) · Comprehensive physiology · doi:10.1002/cphy.cp070208 · Cited by 4 · see citing works
Glucagon Secretion, Function, and Clinical Role
DOBBS, R. E., & Unger, R. H. (1982) · Springer eBooks · doi:10.1007/978-1-4684-4187-1_2 · Cited by 1 · see citing works
Assessment of biologically active parathyroid hormone in hyperparathyroid man.
Nissenson, R., Abbott, S., Pua, K., Zitzner, L., Teitelbaum, A., & Clark, O. H. (1982) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4684-4259-5_58 · Cited by 1
- Authors
- Rizza, R., Verdonk, C., Miles, J., Service, F. J., & Gerich, J.
- Affiliations
- Mayo Clinic (US)
- Venue
- Journal of Clinical Investigation
- Published
- 1979-06-01
- Volume
- 63
- Issue
- 6
- Pages
- 1119-1123
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC372058
- OpenAlex
- W2092283677
- Cited by
- 68
- References
- 0
- Citations by year
- 2025: 1 · 2021: 1 · 2020: 2 · 2016: 1 · 2015: 2 · 2014: 1 · 2013: 2 · 2012: 1
- FWCI
- 8.03
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Surgery › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- L-arginine, glucagon secretion, glucose homeostasis, type 1 diabetes, somatostatin, glucose production, hyperglycemia, beta-cell function, insulin secretion
- MeSH terms
- Adolescent, Adult, Arginine, Blood Glucose, Diabetes Mellitus, Female, Glucagon, Humans, Insulin, Kinetics, Male, Middle Aged, Somatostatin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
